- Home
- SAGE vs ODP Comparison
SAGE vs ODP Comparison
Compare SAGE & ODP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- ODP
- Stock Information
- Founded
- SAGE 2010
- ODP 1986
- Country
- SAGE United States
- ODP United States
- Employees
- SAGE N/A
- ODP N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- ODP Other Specialty Stores
- Sector
- SAGE Health Care
- ODP Consumer Discretionary
- Exchange
- SAGE Nasdaq
- ODP Nasdaq
- Market Cap
- SAGE 415.0M
- ODP 473.2M
- IPO Year
- SAGE 2014
- ODP N/A
- Fundamental
- Price
- SAGE $7.79
- ODP $13.32
- Analyst Decision
- SAGE Hold
- ODP Hold
- Analyst Count
- SAGE 19
- ODP 1
- Target Price
- SAGE $9.88
- ODP $28.00
- AVG Volume (30 Days)
- SAGE 1.2M
- ODP 1.1M
- Earning Date
- SAGE 04-29-2025
- ODP 05-07-2025
- Dividend Yield
- SAGE N/A
- ODP N/A
- EPS Growth
- SAGE N/A
- ODP N/A
- EPS
- SAGE N/A
- ODP N/A
- Revenue
- SAGE $41,243,000.00
- ODP $6,990,000,000.00
- Revenue This Year
- SAGE $100.64
- ODP N/A
- Revenue Next Year
- SAGE $70.19
- ODP N/A
- P/E Ratio
- SAGE N/A
- ODP $4.24
- Revenue Growth
- SAGE N/A
- ODP N/A
- 52 Week Low
- SAGE $4.62
- ODP $11.85
- 52 Week High
- SAGE $14.97
- ODP $52.60
- Technical
- Relative Strength Index (RSI)
- SAGE 56.30
- ODP 46.48
- Support Level
- SAGE $7.56
- ODP $12.32
- Resistance Level
- SAGE $7.89
- ODP $13.49
- Average True Range (ATR)
- SAGE 0.36
- ODP 1.16
- MACD
- SAGE 0.06
- ODP 0.15
- Stochastic Oscillator
- SAGE 88.03
- ODP 59.51
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About ODP The ODP Corporation
The ODP Corp operates an integrated B2B distribution platform with divisions focusing on various sectors: ODP Business Solutions serves small to enterprise-level companies with office supplies, technology, furniture, and services. Office Depot Division caters to retail consumers and small businesses through retail locations and eCommerce platforms, offering office supplies, technology, and business services. Veyer Division specializes in supply chain, distribution, and procurement services for both internal and third-party customers, with a focus on global operations. Varis Division offers a tech-enabled B2B indirect procurement marketplace, providing a seamless buying experience and advanced spend management tools. Revenue primarily stems from the Veyer division.